| Nov 11 |
Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in Australia
|
| Nov 6 |
Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024
|
| Oct 29 |
Presenting on the Emerging Growth Conference 76 Day 1 on October 30 Register Now
|
| Oct 25 |
OTC Markets Hosts Virtual Investor Presentation with Jim Frakes, Interim CEO & CFO, and Steven LaRosa, MD, Chief Medical Officer, of Aethlon Medical Inc., with Marla Marin, Senior Analyst at Zacks SCR
|
| Oct 9 |
Aethlon Medical Inc (AEMD) Q1 2025 Earnings Call Highlights: Strategic Cost Management and ...
|
| Oct 8 |
Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit
|
| Sep 24 |
AEMD: Positive Takeaways from Life Science Investor Forum Presentation
|
| Sep 24 |
Presenting on the Emerging Growth Conference 75 Day 1 on September 25 Register Now
|
| Sep 20 |
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
|
| Sep 19 |
Immunotherapy Clinical Trials - A New Approach to Treating Cancer
|
